Cargando…
Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma
Few approaches have been made toward exploring autologous NK cells in settings of cancer immunotherapy. Here, we demonstrate the feasibility of infusing multiple doses of ex vivo activated and expanded autologous NK cells in patients with multiple myeloma (MM) post-autologous stem cell transplantati...
Autores principales: | Nahi, Hareth, Chrobok, Michael, Meinke, Stephan, Gran, Charlotte, Marquardt, Nicole, Afram, Gabriel, Sutlu, Tolga, Gilljam, Mari, Stellan, Birgitta, Wagner, Arnika K., Blomberg, Pontus, Holmqvist, Per-Henrik, Walther-Jallow, Lilian, Mellström, Karin, Liwing, Johan, Gustafsson, Charlotte, Månsson, Robert, Klimkowska, Monika, Gahrton, Gösta, Lund, Johan, Ljungman, Per, Ljunggren, Hans-Gustaf, Alici, Evren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861830/ https://www.ncbi.nlm.nih.gov/pubmed/35243416 http://dx.doi.org/10.1016/j.xcrm.2022.100508 |
Ejemplares similares
-
Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma
por: Nahi, Hareth, et al.
Publicado: (2019) -
Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma
por: Duru, Adil Doganay, et al.
Publicado: (2015) -
The Use of Novel Drugs Can Effectively Improve Response, Delay Relapse and Enhance Overall Survival in Multiple Myeloma Patients with Renal Impairment
por: Uttervall, Katarina, et al.
Publicado: (2014) -
Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma
por: Gran, Charlotte, et al.
Publicado: (2020) -
Conditioning with melphalan 200 mg/m(2) and subsequent ASCT improves progression‐free and overall survival in elderly myeloma patients compared to standard of care
por: Afram, Gabriel, et al.
Publicado: (2022)